Overview

Prostate Cancer Biomarker Enrichment and Treatment Selection

Status:
Recruiting
Trial end date:
2023-07-31
Target enrollment:
Participant gender:
Summary
The purpose of the pre-study screening is to test for DNA abnormalities or biomarkers.
Phase:
Phase 2
Details
Lead Sponsor:
Canadian Cancer Trials Group
Collaborators:
BC Cancer Foundation
Canadian Cancer Clinical Trials Network
Treatments:
Adavosertib
Carboplatin
Durvalumab
Tremelimumab